Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Diagnostics & Research

Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs. The company was founded in 1949 and is based in Gurugram, India.

Revenue projections:

Revenue projections for LALPATHLAB
Revenue projections for LALPATHLAB

The projected decline in LALPATHLAB's revenues compared to last year is expected to make investors cautious. A drop in revenue often has a direct negative effect on the company's bottom line, signaling potential challenges that could undermine investor confidence and reduce overall profitability.

Financial Ratios:

currentRatio 0.000000
forwardPE 43.523907
debtToEquity 7.135000
earningsGrowth 0.242000
revenueGrowth 0.113000
grossMargins 0.579930
operatingMargins 0.235440
trailingEps 61.620000
forwardEps 29.380000

Positive earnings and revenue growth for LALPATHLAB point to expected business expansion. The company is projected to continue growing its operations, as increasing profits and sales highlight a strong trajectory for further growth in the future.
Dr. Lal PathLabs Limited's positive gross and operating margins highlight its profitability and operational efficiency. These strong margins demonstrate the company's ability to control costs while generating substantial revenue, contributing to a healthy financial performance.
LALPATHLAB's forward EPS is lower than its trailing EPS, indicating the company may experience reduced profitability. This signals that the company's earnings growth could slow down in the near future.

Price projections:

Price projections for LALPATHLAB
Price projections for LALPATHLAB

Throughout its recent performance, LALPATHLAB's price has been consistently close to the lower range of projected values. This suggests that the company may face challenges in achieving higher valuations in the eyes of investors.

Insider Transactions:

Insider Transactions for LALPATHLAB
Insider Transactions for LALPATHLAB


71 LALPATHLAB shares were sold in recent transactions, with market price at 3135.1887241417253.Dr. Lal PathLabs Limited stock was bought in 1 transactions, while the market price was at 3308.5.LALPATHLAB has experienced more selling activity at current price levels, which could suggest a bearish outlook. If the trend of increased selling continues, it may result in further price declines for the stock.

Recommendation changes over time:

Recommendations trend for LALPATHLAB
Recommendations trend for LALPATHLAB


Analysts' buy bias toward Dr. Lal PathLabs Limited suggests the stock is seen as a solid investment, potentially motivating investors to consider it for their portfolios. With this positive outlook, Dr. Lal PathLabs Limited is likely to be viewed as a secure place to allocate funds, driving further interest in the stock.